Tredje AP-fonden’s Ascendis Pharma A/S ASND Stock Holding History

Tredje AP-fonden’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.45M	Buy	+20,448	New	+$4.78M	0.02%	377

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tredje AP-fonden's ASND Position: Q2 2026 in Review

Tredje AP-fonden opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 20,448 shares worth $5.45M. The stake represents 0.02% of the portfolio and ranks #377 among its holdings.

311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Tredje AP-fonden held 20,448 shares of Ascendis Pharma A/S worth $5.45M as of Q2 2026.
Ascendis Pharma A/S was a new Tredje AP-fonden position in Q2 2026.
Ascendis Pharma A/S made up 0.02% of Tredje AP-fonden's portfolio in Q2 2026, its #377 holding.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.